Transcode Therapeutics (RNAZ) Research & Development (2020 - 2026)
Transcode Therapeutics' Research & Development came in at $3.69 million for Q2 2026, up 44.0% from $2.57 million a year earlier but down 27.7% from the prior quarter.
Powered by 
Analysis
Transcode Therapeutics (RNAZ) Research & Development (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Transcode Therapeutics reported Research & Development of $17.44 million, up 80.7% year-over-year; for FY2025, it came in at $13.42 million, up 38.3% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 116.2% (FY2020 to FY2025).
- Going back by year, Research & Development was $9.71 million in FY2024 (-20.9%), $12.26 million in FY2023 (+19.9%), $10.23 million in FY2022 (+271.6%) and $2.75 million in FY2021 (+868.1%).
- The five-year range for quarterly Research & Development is $992,946 (Q3 2021) to $5.48 million (Q4 2025).
- Year-over-year, Research & Development has increased for four consecutive quarters, with growth averaging 42.1% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 746.7%), and the weakest in Q3 2024 (a decline of 63.3%).
- Business Quant data shows RNAZ's Research & Development at $5.11 million (Q1 2026), $5.48 million (Q4 2025) and $3.16 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Transcode Therapeutics | 1.62 Mn | -40.26 Mn | - | 3.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.69 Mn |
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 5.48 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 3.64 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 3.36 Mn |
| Sep 30, 2023 | 3.34 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Sep 30, 2022 | 3.04 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 992,946.00 |
API Access
Transcode Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RNAZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RNAZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RNAZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();